phoproliferative disorders", "sentences": [], "annotations": [], "relations": []}, {"offset": 38858, "infons": {"fpage": "1793", "issue": "6", "lpage": "1800", "name_0": "surname:Teeling;given-names:JL", "name_1": "surname:French;given-names:RR", "name_2": "surname:Cragg;given-names:MS", "pub-id_pmid": "15172969", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "104", "year": "2004"}, "text": "Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas", "sentences": [], "annotations": [], "relations": []}, {"offset": 38976, "infons": {"fpage": "362", "issue": "1", "lpage": "371", "name_0": "surname:Teeling;given-names:JL", "name_1": "surname:Mackus;given-names:WJ", "name_2": "surname:Wiegman;given-names:LJ", "pub-id_pmid": "16785532", "section_type": "REF", "source": "J\nImmunol", "type": "ref", "volume": "177", "year": "2006"}, "text": "The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20", "sentences": [], "annotations": [], "relations": []}, {"offset": 39073, "infons": {"fpage": "3823", "issue": "16", "lpage": "3837", "name_0": "surname:Glennie;given-names:MJ", "name_1": "surname:French;given-names:RR", "name_2": "surname:Cragg;given-names:MS", "name_3": "surname:Taylor;given-names:RP", "pub-id_pmid": "17768100", "section_type": "REF", "source": "Mol Immunol", "type": "ref", "volume": "44", "year": "2007"}, "text": "Mechanisms of killing by anti-CD20 monoclonal antibodies", "sentences": [], "annotations": [], "relations": []}, {"offset": 39130, "infons": {"fpage": "4519", "issue": "17", "lpage": "4529", "name_0": "surname:Alduaij;given-names:W", "name_1": "surname:Ivanov;given-names:A", "name_2": "surname:Honeychurch;given-names:J", "pub-id_pmid": "21378274", "section_type": "REF", "source": "Blood", "type": "ref", "volume": "117", "year": "2011"}, "text": "Novel type II anti-CD20 monoclonal antibody(GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies", "sentences": [], "annotations": [], "relations": []}, {"offset": 39280, "infons": {"fpage": "2143", "issue": "8", "lpage": "2159", "name_0": "surname:Ivanov;given-names:A", "name_1": "surname:Beers;given-names:SA", "name_2": "surname:Walshe;given-names:CA", "pub-id_pmid": "19620786", "section_type": "REF", "source": "J\nClin Invest", "type": "ref", "volume": "119", "year": "2009"}, "text": "Homotypic adhesion and lysosome-mediated cell death evoked by anti-CD20 (tositumomab) and HLA DR monoclonal antibodies", "sentences": [], "annotations": [], "relations": []}, {"offset": 39399, "infons": {"fpage": "450", "issue": "9", "lpage": "454", "name_0": "surname:Tedder;given-names:TF", "name_1": "surname:Engel;given-names:P", "pub-id_pmid": "7524522", "section_type": "REF", "source": "Immunol Today", "type": "ref", "volume": "15", "year": "1994"}, "text": "CD20: a regulator of cell-cycle progression of B lymphocytes", "sentences": [], "annotations": [], "relations": []}, {"offset": 39460, "infons": {"fpage": "802", "issue": "6", "lpage": "812", "name_0": "surname:Plavina;given-names:T", "name_1": "surname:Subramanyam;given-names:M", "name_2": "surname:Bloomgren;given-names:G", "pub-id_pmid": "25273271", "section_type": "REF", "source": "Ann Neurol", "type": "ref", "volume": "76", "year": "2014"}, "text": "Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy", "sentences": [], "annotations": [], "relations": []}, {"offset": 39598, "infons": {"fpage": "161", "issue": "2", "lpage": "170", "name_0": "surname:O'Shea;given-names:JJ", "name_1": "surname:Holland;given-names:SM", "name_2": "surname:Staudt;given-names:LM", "pub-id_pmid": "23301733", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "368", "year": "2013"}, "text": "JAKs and STATs in immunity, immunodeficiency, and cancer", "sentences": [], "annotations": [], "relations": []}, {"offset": 39655, "infons": {"fpage": "641", "issue": "7", "lpage": "648", "name_0": "surname:Tur;given-names:C", "name_1": "surname:Montalban;given-names:X", "pub-id_pmid": "24942634", "section_type": "REF", "source": "CNS Drugs", "type": "ref", "volume": "28", "year": "2014"}, "text": "Natalizumab: risk stratification of individual patients with multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39735, "infons": {"fpage": "837", "issue": "7", "lpage": "842", "name_0": "surname:Jilek;given-names:S", "name_1": "surname:Mathias;given-names:A", "name_2": "surname:Canales;given-names:M", "pub-id_pmid": "24258149", "section_type": "REF", "source": "Mult\nScler", "type": "ref", "volume": "20", "year": "2014"}, "text": "Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 alpha-chain(CD11a) in MS patients